Literature DB >> 25312814

Protein 'pre-loads' in type 2 diabetes: what do we know and what do we need to find out?

Christopher K Rayner1, Jing Ma, Karen L Jones, Peter M Clifton, Michael Horowitz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25312814     DOI: 10.1007/s00125-014-3410-x

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


× No keyword cloud information.
  8 in total

Review 1.  Biochemical and metabolic mechanisms by which dietary whey protein may combat obesity and Type 2 diabetes.

Authors:  Daniela Jakubowicz; Oren Froy
Journal:  J Nutr Biochem       Date:  2012-09-17       Impact factor: 6.048

2.  Contributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c).

Authors:  Louis Monnier; Hélène Lapinski; Claude Colette
Journal:  Diabetes Care       Date:  2003-03       Impact factor: 19.112

Review 3.  Mechanisms and clinical efficacy of lixisenatide for the management of type 2 diabetes.

Authors:  Michael Horowitz; Christopher K Rayner; Karen L Jones
Journal:  Adv Ther       Date:  2013-02-13       Impact factor: 3.845

4.  Glucagon and insulin responses after ingestion of different amounts of intact and hydrolysed proteins.

Authors:  Mandy Claessens; Wim H M Saris; Marleen A van Baak
Journal:  Br J Nutr       Date:  2008-01-02       Impact factor: 3.718

5.  Incretin, insulinotropic and glucose-lowering effects of whey protein pre-load in type 2 diabetes: a randomised clinical trial.

Authors:  Daniela Jakubowicz; Oren Froy; Bo Ahrén; Mona Boaz; Zohar Landau; Yosefa Bar-Dayan; Tali Ganz; Maayan Barnea; Julio Wainstein
Journal:  Diabetologia       Date:  2014-07-10       Impact factor: 10.122

6.  Effects of a protein preload on gastric emptying, glycemia, and gut hormones after a carbohydrate meal in diet-controlled type 2 diabetes.

Authors:  Jing Ma; Julie E Stevens; Kimberly Cukier; Anne F Maddox; Judith M Wishart; Karen L Jones; Peter M Clifton; Michael Horowitz; Christopher K Rayner
Journal:  Diabetes Care       Date:  2009-06-18       Impact factor: 19.112

7.  Effects of a D-xylose preload with or without sitagliptin on gastric emptying, glucagon-like peptide-1, and postprandial glycemia in type 2 diabetes.

Authors:  Tongzhi Wu; Michelle J Bound; Beiyi R Zhao; Scott D Standfield; Max Bellon; Karen L Jones; Michael Horowitz; Christopher K Rayner
Journal:  Diabetes Care       Date:  2013-01-28       Impact factor: 19.112

Review 8.  Relationships between gastric emptying, postprandial glycemia, and incretin hormones.

Authors:  Chinmay S Marathe; Christopher K Rayner; Karen L Jones; Michael Horowitz
Journal:  Diabetes Care       Date:  2013-05       Impact factor: 19.112

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.